LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Search

Viatris Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

8.91 -1.87

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.9

Max

9.08

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-2.5B

-3B

Pardavimai

-274M

3.3B

Pelnas, tenkantis vienai akcijai

0.5

Dividendų pajamingumas

5.45

Pelno marža

-93.476

Darbuotojai

32,000

EBITDA

-2.7B

-2.3B

Rekomendacijos

By TipRanks

Rekomendacijos

Parduoti

12 mėnesių prognozė

-3.92% downside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

5.45%

2.35%

Kitas uždarbis

2025-08-07

Kitas dividendų mokėjimo data

2025-06-16

Kita Ex Dividend data

2025-08-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

492M

10B

Ankstesnė atidarymo kaina

10.78

Ankstesnė uždarymo kaina

8.91

Naujienos nuotaikos

By Acuity

50%

50%

177 / 380 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Viatris Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-13 22:33; UTC

Įsigijimai, susijungimai, perėmimai

Millicom to Acquire Telefonica Ecuador for $380 Million

2025-06-13 23:50; UTC

Įsigijimai, susijungimai, perėmimai

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

2025-06-13 23:20; UTC

Įsigijimai, susijungimai, perėmimai

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

2025-06-13 23:09; UTC

Įsigijimai, susijungimai, perėmimai

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

2025-06-13 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

2025-06-13 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Millicom to Acquire Telefonica Ecuador for $380M

2025-06-13 22:04; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Better Data Facilitate Investments In Oil Patch -- Market Talk

2025-06-13 21:42; UTC

Įsigijimai, susijungimai, perėmimai

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

2025-06-13 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Bunge: Outside Date Extended to July 3

2025-06-13 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Bunge: Subject to Satisfaction of Remaining Conditions, Bunge and Sellers Expect to Complete Transaction July 2

2025-06-13 21:34; UTC

Įsigijimai, susijungimai, perėmimai

Bunge Gets Mexico Approval for Viterra Deal

2025-06-13 21:32; UTC

Įsigijimai, susijungimai, perėmimai

Bunge Gets China Approval for Viterra Deal

2025-06-13 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-13 20:45; UTC

Įsigijimai, susijungimai, perėmimai

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

2025-06-13 20:34; UTC

Įsigijimai, susijungimai, perėmimai

Anne Wojcicki Wins Bidding for 23andMe -- Update

2025-06-13 20:14; UTC

Įsigijimai, susijungimai, perėmimai

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

2025-06-13 20:14; UTC

Įsigijimai, susijungimai, perėmimai

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

2025-06-13 20:14; UTC

Įsigijimai, susijungimai, perėmimai

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

2025-06-13 19:30; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2025-06-13 19:12; UTC

Rinkos pokalbiai

Oil Futures Jump As Israel Strikes Iranian Targets -- Market Talk

2025-06-13 19:04; UTC

Rinkos pokalbiai

Canada Military Spending Hike to Lift Long-Term Yields -- Market Talk

2025-06-13 18:54; UTC

Rinkos pokalbiai

Correction to Gold Settles Market Talk

2025-06-13 18:01; UTC

Rinkos pokalbiai

Gold Settles at Record High -- Market Talk

2025-06-13 17:40; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Falls By 3 to 439 -- Market Talk

2025-06-13 17:21; UTC

Rinkos pokalbiai

Dollar Index, Commodities Rise -- Market Talk

2025-06-13 17:02; UTC

Įsigijimai, susijungimai, perėmimai

Advent Proposal Values Spectris at GBP37.63 Per Share, Company Said Monday -- WSJ

2025-06-13 17:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR Is Preparing a Bid for High-Tech Instrument Maker Spectris, Sources Say -- WSJ

2025-06-13 17:02; UTC

Įsigijimai, susijungimai, perėmimai

Private-Equity Firm Is Vying With Advent for the U.K. Company, Sources Say -- WSJ

2025-06-13 17:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR Making Competing Bid for Equipment Maker Spectris -- WSJ

2025-06-13 16:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Viatris Inc Prognozė

Kainos tikslas

By TipRanks

-3.92% į apačią

12 mėnesių prognozė

Vidutinis 8.57 USD  -3.92%

Aukščiausias 9 USD

Žemiausias 8 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Viatris Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Parduoti

3 ratings

0

Pirkti

2

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

8.48 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

177 / 380 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.